• Users Online: 484
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2018  |  Volume : 27  |  Issue : 1  |  Page : 1-6

Outcomes in palliative care for advanced prostate cancer in the radiotherapy and oncology department of the ahmadu bello university teaching hospital, Zaria


Department of Radiotherapy and Oncology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria

Correspondence Address:
A Adamu
Department of Radiotherapy and Oncology, Ahmadu Bello University Teaching Hospital, Zaria
Nigeria
I C Chukwuocha
Department of Radiotherapy and Oncology, Ahmadu Bello University Teaching Hospital, Zaria
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1115-2613.278224

Rights and Permissions

BACKGROUND: Adoption of palliative care approach in the management of advanced prostate cancer is important because of the advanced nature of the disease, long course of disease and the fact that prostate cancer predominantly affects the elderly people who are at greater risk of having other comorbidities. Most patients with prostate cancer present at an advanced stage in Radiotherapy and Oncology Department (ABUTH) requiring the use of palliative radiotherapy, chemotherapy, hormonal manipulations, bisphosphonates, analgesics, psychosocial, spiritual and financial support. AIM: The aim was to evaluate the effect of palliative care in the management of advanced prostate cancer. The objectives were to determine the effect of palliative external beam radiotherapy, chemotherapy, bisphosphonates and analgesics insymptom control. This study is a 9 years retrospective study of patients with advanced prostate cancer from January 2006 toDecember 2014. Information was obtained from the treatment cards as well as case files. RESULTS: Results showed that 139 patients received palliative External Beam Radiotherapy (EBRT). Commonest indication was pain of bone metastases seen in 84(60%) patients. Others included obstructive uropathy in 41(30%) patients, spinal cord compression in 8(6%) patients and bleeding in 6 (4%) patients. One hundred and eight (77.7%) patients received analgesics and 123 (88.5%) patients received haematinics. Bisphosphonates were administered to 34(24%) patients, while 26(17%) patients received chemotherapy. These various forms of treatment resulted in good symptom control and improved quality of life. CONCLUSION: Palliative care plays a pivotal role in the management of advanced prostate cancer, and the earlier it is commenced, the better the outcome for the patients.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed238    
    Printed17    
    Emailed0    
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal